Literature DB >> 9198156

Conjunctive use of platelet glycoprotein IIb/IIIa antagonists and thrombolytic therapy for acute myocardial infarction.

D J Moliterno1, E J Topol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9198156

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  5 in total

Review 1.  Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB/IIIA inhibitors.

Authors:  M T Roe; D J Moliterno
Journal:  J Thromb Thrombolysis       Date:  1999-06       Impact factor: 2.300

Review 2.  Glycoprotein IIb/IIIa receptor antagonists: clinical pharmacology in cardiovascular diseases of aging.

Authors:  M Sebastian; R Makkar
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

Review 3.  Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention.

Authors:  K L Goa; S Noble
Journal:  Drugs       Date:  1999-03       Impact factor: 9.546

4.  Use of antiplatelet inhibitors in peripheral vascular interventions.

Authors:  S William Stavropoulos; Richard D Shlansky-Goldberg
Journal:  Semin Intervent Radiol       Date:  2005-06       Impact factor: 1.513

Review 5.  Plateletworks: a novel point of care platelet function screen.

Authors:  James Campbell; Helen Ridgway; David Carville
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.